From: Understanding the patient journey to diagnosis of lung cancer
Patients with w/EMR at Tulane and Ochsner and have confirmed diagnosis in LA tumor registry (N = 1496) | Patients without primary lung cancer with SPN and 1-year follow up (N = 15,978) | |
---|---|---|
Age, mean (SD) | 68.41 (10.03) | 61.74 (15.19) |
Age group, N (%) | ||
18–34 years old | 4 (0.27) | 958 (6.00) |
35–44 years old | 14 (0.94) | 1186 (7.42) |
45–54 years old | 100 (6.68) | 2351 (14.71) |
55–64 years old | 382 (25.53) | 4138 (25.90) |
≥ 65 years old | 996 (66.58) | 7345 (45.97) |
Gender, N (%) | ||
Male | 843 (56.35) | 7139 (44.68) |
Female | 651 (43.52) | 8839 (55.32) |
Race, N (%) | ||
White | 976 (65.24) | 10,461 (65.47) |
Black | 504 (33.69) | 5225 (32.70) |
aOther | 16 (1.07) | 292 (1.83) |
Region, N (%) | ||
Outside New Orleans | 258 (17.25) | n/a |
New Orleans Area | 1237 (82.69) | |
Health insurance type at diagnosis, N (%) | ||
Medicare | 1010 (67.51) | n/a |
Private Insurance | 235 (15.71) | |
Medicaid | 92 (6.15) | |
Insurance not specified | 76 (5.08) | |
TRICARE/Veterans Affairs | 49 (3.28) | |
Not insured | 24 (1.60) | |
Insurance status unknown | 10 (0.67) | |
Year of diagnosis, N (%) | ||
2013 | 165 (11.03) | n/a |
2014 | 312 (20.86) | |
2015 | 317 (21.19) | |
2016 | 347 (23.20) | |
2017 | 355 (23.73) | |
AJCC stage, N (%) | ||
Stage 0 | 9 (0.60) | n/a |
Stage I | 308 (20.59) | |
Stage II | 108 (7.22) | |
Stage III | 327 (21.86) | |
Stage IV | 707 (47.26) | |
Unknown, not staged | 37 (2.47) | |
Overall: | ||
Average number of invasive proceduresb from index date to diagnosis date or end of study periodc, mean (SD) | 2.11 (0.75) | 1.58 (1.66) |
Average number of non-invasive procedures from index date to diagnosis date or end of study periodc, mean (SD) | 5.88 (7.68) | 10.47 (9.68) |